Invivyd (IVVD) Competitors $0.51 +0.04 (+8.21%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.50 -0.01 (-0.98%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IVVD vs. TKNO, SEPN, ENGN, AVIR, ESPR, SLRN, CADL, SLDB, ACB, and PVLAShould you be buying Invivyd stock or one of its competitors? The main competitors of Invivyd include Alpha Teknova (TKNO), Septerna (SEPN), enGene (ENGN), Atea Pharmaceuticals (AVIR), Esperion Therapeutics (ESPR), Acelyrin (SLRN), Candel Therapeutics (CADL), Solid Biosciences (SLDB), Aurora Cannabis (ACB), and Palvella Therapeutics (PVLA). These companies are all part of the "pharmaceutical products" industry. Invivyd vs. Alpha Teknova Septerna enGene Atea Pharmaceuticals Esperion Therapeutics Acelyrin Candel Therapeutics Solid Biosciences Aurora Cannabis Palvella Therapeutics Invivyd (NASDAQ:IVVD) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, community ranking, earnings and media sentiment. Is IVVD or TKNO more profitable? Invivyd has a net margin of 0.00% compared to Alpha Teknova's net margin of -87.17%. Alpha Teknova's return on equity of -35.30% beat Invivyd's return on equity.Company Net Margins Return on Equity Return on Assets InvivydN/A -155.33% -114.88% Alpha Teknova -87.17%-35.30%-24.52% Which has more risk and volatility, IVVD or TKNO? Invivyd has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Does the media refer more to IVVD or TKNO? In the previous week, Invivyd had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 1 mentions for Invivyd and 0 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.00 beat Invivyd's score of -0.50 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Overall Sentiment Invivyd Negative Alpha Teknova Neutral Do institutionals & insiders have more ownership in IVVD or TKNO? 70.4% of Invivyd shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 17.9% of Invivyd shares are owned by insiders. Comparatively, 15.2% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer IVVD or TKNO? Invivyd received 15 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 85.71% of users gave Invivyd an outperform vote while only 39.13% of users gave Alpha Teknova an outperform vote. CompanyUnderperformOutperformInvivydOutperform Votes2485.71% Underperform Votes414.29%Alpha TeknovaOutperform Votes939.13% Underperform Votes1460.87% Which has higher earnings and valuation, IVVD or TKNO? Alpha Teknova has higher revenue and earnings than Invivyd. Alpha Teknova is trading at a lower price-to-earnings ratio than Invivyd, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInvivyd$25.38M2.41-$198.64M-$1.44-0.35Alpha Teknova$37.75M8.15-$36.78M-$0.59-9.76 Do analysts recommend IVVD or TKNO? Invivyd presently has a consensus price target of $7.52, indicating a potential upside of 1,373.86%. Alpha Teknova has a consensus price target of $8.50, indicating a potential upside of 47.57%. Given Invivyd's stronger consensus rating and higher probable upside, analysts clearly believe Invivyd is more favorable than Alpha Teknova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Invivyd 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Alpha Teknova 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryInvivyd beats Alpha Teknova on 11 of the 19 factors compared between the two stocks. Get Invivyd News Delivered to You Automatically Sign up to receive the latest news and ratings for IVVD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IVVD vs. The Competition Export to ExcelMetricInvivydBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.18M$2.84B$5.30B$7.34BDividend YieldN/A1.86%5.12%4.30%P/E Ratio-0.2630.4821.8017.78Price / Sales2.41441.91379.9697.74Price / CashN/A168.6838.2634.64Price / Book0.323.466.443.97Net Income-$198.64M-$72.06M$3.21B$247.65M7 Day Performance-7.10%2.56%2.85%1.80%1 Month Performance-36.71%-15.70%-8.64%-6.98%1 Year Performance-78.30%-26.10%11.38%1.34% Invivyd Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IVVDInvivyd2.4605 of 5 stars$0.51+8.2%$7.52+1,373.9%-79.4%$61.18M$25.38M-0.26100Short Interest ↑Gap UpTKNOAlpha Teknova1.1833 of 5 stars$4.51-3.6%$8.50+88.5%+173.0%$241.00M$37.75M-6.09240Positive NewsGap UpSEPNSepterna1.9743 of 5 stars$5.38-1.8%$33.00+513.4%N/A$239.10M$1.08M0.00N/ALockup ExpirationPositive NewsENGNenGene3.1009 of 5 stars$4.68+4.0%$25.22+438.9%-74.6%$238.57MN/A-8.0731Analyst RevisionAVIRAtea Pharmaceuticals2.3293 of 5 stars$2.78-0.4%$6.88+147.5%-19.9%$237.76MN/A-1.3470News CoverageGap UpESPREsperion Therapeutics3.6775 of 5 stars$1.20-2.4%$6.75+462.5%-48.4%$237.42M$332.31M-1.88200Analyst ForecastSLRNAcelyrin3.5449 of 5 stars$2.31-4.9%$9.60+315.6%-56.2%$232.64MN/A-0.94135Short Interest ↓Positive NewsCADLCandel Therapeutics2.2908 of 5 stars$4.84+0.4%$21.00+333.9%-16.0%$228.62M$120,000.00-2.8060Short Interest ↑SLDBSolid Biosciences3.3487 of 5 stars$2.94-5.8%$15.67+432.9%-74.5%$227.83M$8.09M-0.97100ACBAurora Cannabis0.4274 of 5 stars$4.05+0.7%N/A-23.3%$227.67M$320.81M81.021,340PVLAPalvella Therapeutics3.6368 of 5 stars$20.07-16.3%$43.50+116.7%N/A$221.15M$42.81M-1.66N/A Related Companies and Tools Related Companies TKNO Competitors SEPN Competitors ENGN Competitors AVIR Competitors ESPR Competitors SLRN Competitors CADL Competitors SLDB Competitors ACB Competitors PVLA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IVVD) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invivyd, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Invivyd With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IVVD Stock Free IVVD Stock Alerts